Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
ABGENIX INC (ABGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/29/2006 8-K Quarterly results
03/15/2006 10-K Annual Report for the period ended December 31, 2005
03/10/2006 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/21/2006 8-K Quarterly results
Docs: "ABGENIX ANNOUNCES 2005 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
02/14/2006 SC 13G/A WELLINGTON MANAGEMENT CO LLP reports a 13.5% stake in Abgenix, Inc.
02/14/2006 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 6.1% stake in ABGENIX, INC.
02/13/2006 SC 13G/A CITADEL L P reports a 3% stake in Abgenix, Inc.
02/13/2006 SC 13G CITIGROUP INC reports a 5.1% stake in Abgenix, Inc.
02/08/2006 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
02/02/2006 SC 13G/A ORBIMED ADVISORS LLC reports a 8.7% stake in Abgenix Inc.
02/01/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
01/19/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
01/12/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
01/12/2006 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]
01/09/2006 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/23/2005 8-K Other Events
12/22/2005 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/20/2005 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/19/2005 8-K Entry into a Material Definitive Agreement
12/15/2005 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/15/2005 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Amgen Inc., Athletics Merger Sub, Inc. and Abgenix, Inc",
"AMGEN TO ACQUIRE ABGENIX FOR $22.50 PER SHARE"
12/14/2005 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/14/2005 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/07/2005 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]
11/09/2005 10-Q Quarterly Report for the period ended September 30, 2005
11/08/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "PANITUMUMAB SIGNIFICANTLY IMPROVES PROGRESSION-FREE SURVIVAL IN PHASE 3 RANDOMIZED METASTATIC COLORECTAL CANCER STUDY"
10/25/2005 8-K Quarterly results
Docs: "Abgenix Announces Third Quarter 2005 Financial Results"
09/27/2005 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws of Abgenix, Inc"
08/26/2005 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/09/2005 10-Q Quarterly Report for the period ended June 30, 2005
08/02/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "ABGENIX AND AMGEN ANNOUNCE FDA GRANTS PANITUMUMAB FAST TRACK DESIGNATION FOR METASTATIC COLORECTAL CANCER"
07/26/2005 8-K Quarterly results
Docs: "Abgenix Announces Second Quarter 2005 Financial Results"
07/15/2005 SC 13G CITADEL L P reports a 5.4% stake in Abgenix, Inc.
06/28/2005 8-K Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits
Docs: "ABGENIX TO CONSOLIDATE RESEARCH FACILITIES IN PREPARATION FOR EXPANDED DEVELOPMENT AND COMMERCIAL OPERATIONS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy